| 791 | Humans |
| 460 | Female |
| 310 | Male |
| 279 | Middle Aged |
| 256 | Adult |
| 205 | Aged |
| 185 | Lymphedema (etiology) |
| 165 | Animals |
| 164 | Lymphedema |
| 103 | Adolescent |
| 93 | Lymphedema (therapy) |
| 88 | Aged, 80 and over |
| 87 | Human |
| 80 | Elephantiasis, Filarial (epidemiology) |
| 80 | Child |
| 73 | Lymphedema (diagnosis) |
| 71 | Breast Neoplasms (surgery) |
| 70 | Treatment Outcome |
| 69 | Elephantiasis, Filarial (prevention & control) |
| 68 | Lymphedema (complications) |
| 67 | Prevalence |
| 62 | Young Adult |
| 62 | Lymphedema (pathology) |
| 62 | Chronic Disease |
| 60 | Elephantiasis, Filarial (drug therapy) |
| 58 | Breast Neoplasms (complications) |
| 57 | Lymphedema (physiopathology) |
| 52 | Lymphedema (genetics) |
| 52 | Lymphedema (diagnostic imaging) |
| 49 | Quality of Life |
| 48 | Treatment |
| 47 | Surveys and Questionnaires |
| 46 | Child, Preschool |
| 45 | Risk Factors |
| 43 | Elephantiasis, Filarial (transmission) |
| 41 | Axilla |
| 39 | Lymphedema (surgery) |
| 39 | Filaricides (therapeutic use) |
| 39 | Elephantiasis, Filarial (parasitology) |
| 37 | Lymphedema (epidemiology) |
| 37 | Breast Neoplasms (pathology) |
| 33 | United Kingdom |
| 33 | Retrospective Studies |
| 33 | Mutation |
| 33 | Lymphatic Metastasis |
| 33 | Leg |
| 32 | Case study |
| 32 | Bandages |
| 31 | Lymphedema (nursing) |
| 31 | Follow-Up Studies |
| 30 | Lymphedema (prevention & control) |
| 29 | Diagnosis, Differential |
| 29 | Arm |
| 28 | Complication |
| 27 | Phenotype |
| 27 | Lymphography |
| 27 | Elephantiasis, Filarial (immunology) |
| 26 | Time Factors |
| 26 | Infant |
| 26 | Breast Neoplasms (radiotherapy) |
| 25 | Prospective Studies |
| 25 | Breast Neoplasms (therapy) |
| 24 | Elephantiasis (epidemiology) |
| 24 | Cross-Sectional Studies |
| 23 | Severity of Illness Index |
| 23 | Mice |
| 23 | Mastectomy |
| 23 | Lymphedema (psychology) |
| 23 | Breast cancer |
| 22 | Pedigree |
| 22 | Lymphedema (congenital) |
| 21 | Stockings, Compression |
| 21 | Prognosis |
| 21 | Mammary gland |
| 21 | Lymphoscintigraphy |
| 21 | Lymph Nodes (pathology) |
| 21 | Lymph Node Excision |
| 21 | Lymph Node Excision (adverse effects) |
| 21 | Ethiopia |
| 21 | Ethiopia (epidemiology) |
| 20 | Syndrome |
| 20 | Radionuclide Imaging |
| 20 | Mastectomy (adverse effects) |
| 20 | Malignant tumor |
| 19 | Surgery |
| 19 | Infant, Newborn |
| 19 | Drainage |
| 18 | Wuchereria bancrofti (isolation & purification) |
| 18 | Massage |
| 18 | Case-Control Studies |
| 17 | Upper limb |
| 17 | Reproducibility of Results |
| 17 | Lymphatic system |
| 17 | Lymphatic System (physiopathology) |
| 17 | Lymph Node Excision (methods) |
| 17 | Incidence |
| 17 | Elephantiasis, Filarial (diagnosis) |
| 17 | Elephantiasis, Filarial (complications) |
| 16 | Skin Neoplasms (pathology) |
| 16 | Review |
| 16 | Randomized Controlled Trials as Topic |
| 16 | Radiotherapy |
| 16 | Ivermectin (therapeutic use) |
| 16 | Insect Vectors (parasitology) |
| 16 | Edema (etiology) |
| 16 | Chronic |
| 16 | Age Factors |
| 15 | Wuchereria bancrofti |
| 15 | Pressure |
| 15 | Patient Education as Topic |
| 15 | Neoplasms (complications) |
| 15 | Global Health |
| 15 | Focus Groups |
| 15 | Albendazole (therapeutic use) |
| 14 | Wuchereria bancrofti (immunology) |
| 14 | Skin Care (methods) |
| 14 | Recurrence |
| 14 | Neglected Diseases (prevention & control) |
| 14 | Lower limb |
| 14 | Health Knowledge, Attitudes, Practice |
| 14 | Elephantiasis (prevention & control) |
| 14 | Dermatology |
| 13 | Socioeconomic Factors |
| 13 | Postoperative Complications |
| 13 | Morbidity |
| 13 | Models, Biological |
| 13 | Magnetic Resonance Imaging |
| 13 | Leg (pathology) |
| 13 | Breast Neoplasms (psychology) |
| 13 | Anopheles (parasitology) |
| 12 | Vascular Endothelial Growth Factor Receptor-3 (genetics) |
| 12 | Skin |
| 12 | Qualitative Research |
| 12 | Postoperative Complications (etiology) |
| 12 | Nursing Assessment |
| 12 | Neoplasm Staging |
| 12 | Lymphedema (drug therapy) |
| 12 | Lymphatic System (physiology) |
| 12 | Lymph Nodes (surgery) |
| 12 | Exercise Therapy |
| 12 | Elephantiasis (etiology) |
| 12 | Disease Models, Animal |
| 12 | Arm (blood supply) |
| 12 | Anti-Bacterial Agents (therapeutic use) |
| 12 | Anthelmintics (therapeutic use) |
| 11 | Ultrasonography |
| 11 | Tropical medicine |
| 11 | Surgical Flaps |
| 11 | Sentinel Lymph Node Biopsy |
| 11 | Rural Population |
| 11 | Onchocerciasis (prevention & control) |
| 11 | Onchocerciasis (drug therapy) |
| 11 | Lymphatic System (pathology) |
| 11 | Lymph (physiology) |
| 11 | Interviews as Topic |
| 11 | Immunohistochemistry |
| 11 | Health Services Needs and Demand |
| 11 | Hand |
| 11 | Genetics |
| 11 | Eyelashes (abnormalities) |
| 11 | Exploration |
| 11 | Equipment Design |
| 11 | Edema (diagnosis) |
| 11 | Drug Therapy, Combination |
| 11 | Diagnosis |
| 11 | Breast Neoplasms (physiopathology) |
| 11 | Arm (diagnostic imaging) |
| 10 | Wuchereria bancrofti (drug effects) |
| 10 | Wound Healing |
| 10 | Tropical Medicine |
| 10 | Tomography, X-Ray Computed |
| 10 | Soil |
| 10 | Social Support |
| 10 | Skin Care (nursing) |
| 10 | Risk Assessment |
| 10 | Predictive Value of Tests |
| 10 | Practice Guidelines as Topic |
| 10 | Palliative Care |
| 10 | Nurse's Role |
| 10 | Mosquito Control (methods) |
| 10 | Molecular Sequence Data |
| 10 | Lymphedema (classification) |
| 10 | Lymphatic vessel disease |
| 10 | Lymphatic filariasis |
| 10 | Lymph Nodes (diagnostic imaging) |
| 10 | Limb |
| 10 | Leg (diagnostic imaging) |
| 10 | India |
| 10 | Filaricides (administration & dosage) |
| 10 | Family study |
| 10 | Elephantiasis (pathology) |
| 10 | Diethylcarbamazine (therapeutic use) |
| 10 | Combined Modality Therapy |
| 10 | Attitude to Health |
| 10 | Arm (pathology) |
| 9 | United Kingdom (epidemiology) |
| 9 | Self Care |
| 9 | Public Health |
| 9 | Neglected Diseases (epidemiology) |
| 9 | Models, Theoretical |
| 9 | Microfilariae (isolation & purification) |
| 9 | Lymphedema (metabolism) |
| 9 | Lymphedema (blood) |
| 9 | Lymphatic Vessels (pathology) |
| 9 | Gerbillinae |
| 9 | Evidence-Based Medicine |
| 9 | England |
| 9 | Endemic Diseases |
| 9 | Endemic Diseases (prevention & control) |
| 9 | Elephantiasis |
| 9 | Elephantiasis, Filarial (blood) |
| 9 | Elephantiasis (psychology) |
| 9 | Drainage (methods) |
| 9 | Culicidae (parasitology) |
| 9 | Compression Bandages |
| 9 | Community Health Nursing (methods) |
| 9 | Brugia (immunology) |
| 9 | Association |
| 9 | Antigens, Helminth (immunology) |
| 9 | Adaptation, Psychological |
| 8 | Wuchereria bancrofti (growth & development) |
| 8 | Symptomatology |
| 8 | Skin disease |
| 8 | Skin Neoplasms (etiology) |
| 8 | Sensitivity and Specificity |
| 8 | Scintigraphy |
| 8 | Radiography |
| 8 | Podoconiosis |
| 8 | Patient Selection |
| 8 | Pathophysiology |
| 8 | Pathogenesis |
| 8 | Pain (etiology) |
| 8 | Obesity (complications) |
| 8 | Neglected Diseases (drug therapy) |
| 8 | Malaria (prevention & control) |
| 8 | Lymphedema (parasitology) |
| 8 | Lymphatic |
| 8 | Leg (blood supply) |
| 8 | International Cooperation |
| 8 | Inguinal Canal |
| 8 | Forkhead Transcription Factors (genetics) |
| 8 | Elephantiasis, Filarial (economics) |
| 8 | Elephantiasis (therapy) |
| 8 | Edema |
| 8 | Edema (physiopathology) |
| 8 | Distichiasis |
| 8 | Culex (parasitology) |
| 8 | Cost of Illness |
| 8 | Cardiovascular disease |
| 8 | Breast Neoplasms (drug therapy) |
| 8 | Biopsy |
| 8 | Arm (physiopathology) |
| 8 | Age Distribution |
| 7 | Wuchereria bancrofti (pathogenicity) |
| 7 | Wolbachia (drug effects) |
| 7 | Varicose Ulcer (therapy) |
| 7 | Transcription Factors (genetics) |
| 7 | Technetium |
| 7 | Tanzania (epidemiology) |
| 7 | Skin Neoplasms (surgery) |
| 7 | Skin Care |
| 7 | Skin (pathology) |
| 7 | Self Care (methods) |
| 7 | Radiotherapy, Adjuvant |
| 7 | Radiotherapy (adverse effects) |
| 7 | Pregnancy |
| 7 | Postoperative Period |
| 7 | Physical Therapy Modalities |
| 7 | Onchocerciasis (epidemiology) |
| 7 | Neoplasm Metastasis |
| 7 | Microfilariae |
| 7 | Mice, Inbred BALB C |
| 7 | Medicine |
| 7 | Malawi (epidemiology) |
| 7 | Malaria (transmission) |
| 7 | Lymphography (methods) |
| 7 | Lymphedema (rehabilitation) |
| 7 | Lymphedema (chemically induced) |
| 7 | Lymphatic Vessels (physiology) |
| 7 | Lymphatic Vessels (diagnostic imaging) |
| 7 | Lymph node |
| 7 | Leg Ulcer (etiology) |
| 7 | Filaricides (pharmacology) |
| 7 | Facies |
| 7 | Exercise Therapy (methods) |
| 7 | Epidemiological Monitoring |
| 7 | Elephantiasis, Filarial (therapy) |
| 7 | Elephantiasis (physiopathology) |
| 7 | Elephantiasis (diagnosis) |
| 7 | Edema (therapy) |
| 7 | Edema (nursing) |
| 7 | Disease Management |
| 7 | Developing Countries |
| 7 | Communicable Disease Control (methods) |
| 7 | Cohort Studies |
| 7 | Chemotherapy, Adjuvant |
| 7 | Brugia (growth & development) |
| 7 | Base Sequence |
| 7 | Axilla (surgery) |
| 7 | Antigens, Helminth (blood) |
| 7 | Africa (epidemiology) |
| 6 | filariasis |
| 6 | breast cancer |
| 6 | Wuchereria bancrofti (physiology) |
| 6 | Technique |
| 6 | Stereotyping |
| 6 | Skin (blood supply) |
| 6 | Rural Health |
| 6 | Rats |
| 6 | Rabbits |
| 6 | Patient Care Planning |
| 6 | Mutation (genetics) |
| 6 | Melanoma (surgery) |
| 6 | Massage (methods) |
| 6 | Malawi |
| 6 | Lymphatic Vessels (physiopathology) |
| 6 | Lymphatic System (anatomy & histology) |
| 6 | Leg Ulcer (therapy) |
| 6 | Injections, Subcutaneous |
| 6 | Host-Parasite Interactions |
| 6 | Heterozygote |
| 6 | Hemangiosarcoma (pathology) |
| 6 | Health Surveys |
| 6 | Genotype |
| 6 | Gene |
| 6 | Feasibility Studies |
| 6 | Fatal Outcome |
| 6 | Enzyme-Linked Immunosorbent Assay |
| 6 | Endothelial Cells (metabolism) |
| 6 | Elephantiasis, Filarial (pathology) |
| 6 | Edema (diagnostic imaging) |
| 6 | Drug Administration Schedule |
| 6 | Disease-Free Survival |
| 6 | Disease Eradication (methods) |
| 6 | DNA-Binding Proteins (genetics) |
| 6 | Congenital |
| 6 | Causality |
| 6 | Brugia malayi (immunology) |
| 6 | Brugia (drug effects) |
| 6 | Breast Neoplasms (mortality) |
| 6 | Blotting, Western |
| 6 | Anthropometry |
| 6 | Anthelmintics (administration & dosage) |
| 6 | Amino Acid Sequence |
| 5 | World Health Organization |
| 5 | Venous Insufficiency (physiopathology) |
| 5 | Tropical Climate |
| 5 | Topography, Medical |
| 5 | Testicular Hydrocele (parasitology) |
| 5 | Testicular Hydrocele (etiology) |
| 5 | Testicular Hydrocele (epidemiology) |
| 5 | T-Lymphocytes (immunology) |
| 5 | Survivors (psychology) |
| 5 | Survival Rate |
| 5 | Shoes |
| 5 | Sex Factors |
| 5 | Schistosomiasis (prevention & control) |
| 5 | Rural Population (statistics & numerical data) |
| 5 | Relapse |
| 5 | Regional Blood Flow |
| 5 | Referral and Consultation |
| 5 | Radiotherapy Dosage |
| 5 | Radiopharmaceuticals (administration & dosage) |
| 5 | Program Evaluation |
| 5 | Primary Health Care |
| 5 | Primary Health Care (organization & administration) |
| 5 | Postoperative |
| 5 | Postoperative Complications (prevention & control) |
| 5 | Pilot Projects |
| 5 | Phlebography |
| 5 | Patient Compliance |
| 5 | Papua New Guinea (epidemiology) |
| 5 | Nursing Methodology Research |
| 5 | Nursing Assessment (methods) |
| 5 | Neoplasm Recurrence, Local |
| 5 | Microfilariae (growth & development) |
| 5 | Microcephaly (genetics) |
| 5 | Melanoma (secondary) |
| 5 | Mastectomy (methods) |
| 5 | Malaria (epidemiology) |
| 5 | Lymphatic Metastasis (radiotherapy) |
| 5 | Lymphatic Diseases (etiology) |
| 5 | Lymph |
| 5 | Lower Extremity |
| 5 | Leg (surgery) |
| 5 | Larva |
| 5 | Insecticide-Treated Bednets |
| 5 | Insect Vectors |
| 5 | Infection |
| 5 | Immunoglobulins |
| 5 | Immunoglobulin G (blood) |
| 5 | Hemangiosarcoma (etiology) |
| 5 | Health Status |
| 5 | Health Services Accessibility |
| 5 | Ghana |
| 5 | Genetic determinism |
| 5 | Genetic Predisposition to Disease |
| 5 | Forkhead Transcription Factors |
| 5 | Forearm |
| 5 | Foot |
| 5 | Filariasis (drug therapy) |
| 5 | Family Health |
| 5 | Epidemiology |
| 5 | Epidemiologic Methods |
| 5 | Environment |
| 5 | Endothelial Cells (cytology) |
| 5 | Elephantiasis (genetics) |
| 5 | Dose-Response Relationship, Drug |
| 5 | Disease Eradication |
| 5 | Disability Evaluation |
| 5 | Crohn Disease (complications) |
| 5 | Consensus |
| 5 | Confidence Intervals |
| 5 | Concomitant disease |
| 5 | Comorbidity |
| 5 | Chromosome Mapping |
| 5 | Cellulitis |
| 5 | Breast Neoplasms (rehabilitation) |
| 5 | Breast Neoplasms (diagnostic imaging) |
| 5 | Blood Pressure |
| 5 | Benchmarking |
| 5 | Attitude of Health Personnel |
| 5 | Antibodies, Helminth (immunology) |
| 5 | Amputation |
| 5 | Albendazole (administration & dosage) |
| 5 | Activities of Daily Living |
| 5 | Abnormalities, Multiple (genetics) |
| 4 | lymphoedema |
| 4 | Wuchereria bancrofti (microbiology) |
| 4 | Wuchereria bancrofti (genetics) |
| 4 | Woman |
| 4 | Vascular Endothelial Growth Factor C (genetics) |
| 4 | Varicose Ulcer (physiopathology) |
| 4 | Ultrasonography, Doppler, Color |
| 4 | Trachoma (prevention & control) |
| 4 | Tanzania |
| 4 | Statistics, Nonparametric |
| 4 | Skin Neoplasms (diagnosis) |
| 4 | Skin Neoplasms (complications) |
| 4 | Skin Diseases (diagnosis) |
| 4 | Sierra Leone (epidemiology) |
| 4 | Sex Distribution |
| 4 | Sequence Analysis, DNA |
| 4 | Self Care (psychology) |
| 4 | Scrotum (pathology) |
| 4 | Schistosomiasis (epidemiology) |
| 4 | Schistosomiasis (drug therapy) |
| 4 | Retinal Dysplasia (genetics) |
| 4 | Research Design |
| 4 | Postoperative Complications (therapy) |
| 4 | Postoperative Complications (physiopathology) |
| 4 | Postoperative Complications (epidemiology) |
| 4 | Population Surveillance |
| 4 | Polymerase Chain Reaction |
| 4 | Physical Examination |
| 4 | Penile Diseases (etiology) |
| 4 | Patient Satisfaction |
| 4 | Nigeria (epidemiology) |
| 4 | Neglected Diseases |
| 4 | Neglected Diseases (diagnosis) |
| 4 | Needs Assessment |
| 4 | Myelodysplastic Syndromes (genetics) |
| 4 | Models, Statistical |
| 4 | Microfilariae (drug effects) |
| 4 | Microcirculation |
| 4 | Mice, Knockout |
| 4 | Mathematics |
| 4 | Malformation |
| 4 | Lymphoscintigraphy (methods) |
| 4 | Lymphoedema |
| 4 | Lymphedema (immunology) |
| 4 | Lymphatic System (surgery) |
| 4 | Lymphatic Abnormalities (genetics) |
| 4 | Lymphangitis (epidemiology) |
| 4 | Lymphangioma (pathology) |
| 4 | Lymphangiogenesis |
| 4 | Lymph Nodes (physiopathology) |
| 4 | Longitudinal Studies |
| 4 | Lipectomy |
| 4 | Leukemia, Myeloid, Acute (genetics) |
| 4 | Kinesin (genetics) |
| 4 | Kenya (epidemiology) |
| 4 | Intermittent Pneumatic Compression Devices |
| 4 | Immunoglobulin G |
| 4 | History, 20th Century |
| 4 | History, 19th Century |
| 4 | Helminthiasis (epidemiology) |
| 4 | Helminthiasis (drug therapy) |
| 4 | Genetic Predisposition to Disease (genetics) |
| 4 | Genetic Linkage |
| 4 | Genes, Dominant |
| 4 | GATA2 Transcription Factor (genetics) |
| 4 | Filariasis (immunology) |
| 4 | Family |
| 4 | Eyelid Diseases (pathology) |
| 4 | Extremities |
| 4 | Evaluation |
| 4 | Etiology |
| 4 | Endothelium, Lymphatic (metabolism) |
| 4 | Elephantiasis (complications) |
